Expansion Opportunity MiraVista Diagnostics has announced expansion plans in Indianapolis with commitments to invest in facilities and headcount. This presents a sales opening to supply complementary lab services, instrumentation, or staffing support as they scale operations.

Fungal Diagnostics Leader As a CAP and CLIA certified reference lab focused on invasive fungal infections, MiraVista serves medical and veterinary markets worldwide and may seek partnerships to broaden test menus, improve turnaround times, or access broader distribution channels for fungal antigen and DNA assays.

Rapid Turnaround Their value proposition emphasizes same-day results and prompt access to infectious disease experts, signaling opportunities to offer automation, sample transport, data integration, or LIS/EMR interoperability solutions to sustain fast reporting.

Key Personnel Network The company’s leadership and clinicians publish extensively and operate with a deep Infectious Disease bench, creating potential for collaborative sales motions around new assay development, clinical validations, or joint studies.

Growth Revenue Focus With reported revenue in the mid seven figures and ongoing expansion, there is room to discuss scalable reagents, quality control materials, engineering support, and services for both human and veterinary testing channels to fuel growth.